ArticleJournal of ovarian research2024

The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma.

Hao Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.